Front Desk: 469-391-0070
Mesna Medication: Uses, Dosage, and Bladder Protection
Summary of Key Points
Mesna is a medication used to protect the bladder from harmful side effects caused by certain chemotherapy drugs, such as ifosfamide and cyclophosphamide. It helps prevent bladder irritation and bleeding, a condition known as hemorrhagic cystitis. Mesna is typically administered alongside chemotherapy to reduce the risk of bladder damage. Always consult your healthcare provider before starting or adjusting your Mesna dosage.
Names of Medication
US Brand Name: Mesnex (Mesna)
The generic name is the official medical name of the drug, while the brand name is assigned by the manufacturer. In this article, the generic name is shown in parentheses.
Pharmacologic Category
Category: Uroprotectant
Mesna Dosage Recommendations
Mesna is used to prevent bladder damage caused by certain chemotherapy drugs. Below are the dosing recommendations for various conditions. Always follow your healthcare provider’s instructions and consult them before making any changes to your dose. If you need to speak with a healthcare provider, you can schedule a telemedicine appointment with us.
Hemorrhagic Cystitis (Chemotherapy-Induced)
Initial Dose: 20% of the ifosfamide or cyclophosphamide dose, given intravenously at the same time as chemotherapy.
Subsequent Doses: 20% of the chemotherapy dose, administered 4 and 8 hours after the initial dose.
Duration: Continue dosing throughout chemotherapy treatment.
Bladder Cancer
Initial Dose: 20% of the chemotherapy dose, given intravenously.
Subsequent Doses: 20% of the chemotherapy dose, administered 4 and 8 hours after the initial dose.
Duration: Continue during chemotherapy cycles.
Cyclophosphamide-Induced Cystitis
Initial Dose: 20% of the cyclophosphamide dose, given intravenously at the time of chemotherapy.
Subsequent Doses: 20% of the cyclophosphamide dose, administered 4 and 8 hours after the initial dose.
Duration: Continue during chemotherapy treatment.
Ifosfamide-Induced Cystitis
Initial Dose: 20% of the ifosfamide dose, given intravenously at the time of chemotherapy.
Subsequent Doses: 20% of the ifosfamide dose, administered 4 and 8 hours after the initial dose.
Duration: Continue during chemotherapy treatment.
Chemotherapy-Induced Bladder Toxicity
Initial Dose: 20% of the chemotherapy dose, given intravenously.
Subsequent Doses: 20% of the chemotherapy dose, administered 4 and 8 hours after the initial dose.
Duration: Continue during chemotherapy cycles.
Radiation Cystitis
Initial Dose: 20% of the radiation therapy dose, given intravenously.
Subsequent Doses: 20% of the radiation therapy dose, administered 4 and 8 hours after the initial dose.
Duration: Continue during radiation therapy.
Nephrotoxicity and Renal Toxicity
Initial Dose: 20% of the chemotherapy dose, given intravenously.
Subsequent Doses: 20% of the chemotherapy dose, administered 4 and 8 hours after the initial dose.
Duration: Continue during chemotherapy cycles.
Urinary Tract Infections (UTIs)
Initial Dose: 20% of the chemotherapy dose, given intravenously.
Subsequent Doses: 20% of the chemotherapy dose, administered 4 and 8 hours after the initial dose.
Duration: Continue during chemotherapy cycles.
Bladder Inflammation
Initial Dose: 20% of the chemotherapy dose, given intravenously.
Subsequent Doses: 20% of the chemotherapy dose, administered 4 and 8 hours after the initial dose.
Duration: Continue during chemotherapy cycles.
Dosage Forms and Strengths
Injection: 100 mg/mL solution
Oral Tablets: 400 mg
Administration Instructions for Mesna
Mesna can be administered either intravenously (through an IV) or orally, depending on your treatment plan. If taken by mouth, it is usually given in three doses: one at the time of chemotherapy, followed by two additional doses at 4 and 8 hours after the first dose. If administered intravenously, your healthcare provider will ensure it is given at the appropriate times. Always follow your healthcare provider’s instructions carefully.
Contraindications for Mesna
A contraindication is a specific situation or condition where a medication should not be used because it may be harmful. Before starting any new medication, it’s important to know if there are any reasons to avoid it. Below are the contraindications for taking Mesna:
Hypersensitivity to Mesna: If you have had an allergic reaction to Mesna in the past, you should not take it again. Allergic reactions can range from mild rashes to severe anaphylaxis, which can be life-threatening.
Hypersensitivity to thiol compounds: Mesna contains a thiol group, and if you have a known allergy to thiol compounds, you should avoid Mesna. The body may react similarly to Mesna as it does to other thiol-containing substances.
If you have any of these conditions, it’s essential to discuss them with your healthcare provider. If you’re unsure, one of our telemedicine providers can help you assess your risk and determine if Mesna is safe for you.
Drug-to-Drug Interactions
Mesna can interact with other medications, which may increase the risk of side effects or reduce the effectiveness of either Mesna or the other drug. Below are some known drug interactions:
Warfarin (Coumadin): Mesna may increase the risk of bleeding when taken with blood thinners like warfarin. Your healthcare provider may need to adjust your dose or monitor your blood clotting more closely.
Phenytoin (Dilantin): Mesna may reduce the effectiveness of phenytoin, a medication used to control seizures. If you are taking both, your healthcare provider may need to adjust your phenytoin dose.
Live vaccines: Mesna may weaken your immune system, making live vaccines less effective. It’s important to avoid live vaccines while taking Mesna unless your healthcare provider advises otherwise.
If you are taking any of these medications, or if you are unsure about potential interactions, make sure to consult with your healthcare provider. Our telemedicine team is available to review your medications and help you manage any potential interactions.
html
Mesna in Pregnancy
Is it safe to take Mesna when pregnant?
There is limited information regarding the safety of Mesna during pregnancy. While animal studies have not demonstrated harm to the fetus, no well-controlled studies have been conducted in pregnant women. Mesna should only be used during pregnancy if it is clearly necessary and if the potential benefits outweigh any risks. If you are pregnant or planning to become pregnant, it is important to discuss this with your healthcare provider before starting Mesna. Our telemedicine providers are available to help you evaluate the risks and benefits based on your individual circumstances.
Mesna while Breastfeeding
Is it safe to take Mesna while breastfeeding?
It is not known whether Mesna passes into breast milk. Due to the lack of available data, caution is recommended when using Mesna while breastfeeding. You should consult your healthcare provider to carefully weigh the potential risks and benefits and determine the best course of action for both you and your baby. If you are breastfeeding and need to take Mesna, our telemedicine providers can assist you in making an informed decision.
Estimated Cost of Mesna Medication
The estimated cost of a 30-day supply of Mesna without insurance, using a GoodRX coupon, typically ranges from $100 to $200, depending on the pharmacy and dosage. Prices may vary, so it’s a good idea to check with your local pharmacy or use a discount service like GoodRX to find the most affordable option.
Possible Alternatives to Mesna
If Mesna is not suitable for you, or if you are exploring alternative treatments, other options may be available depending on your condition. Below are some potential alternatives for the conditions Mesna is commonly used to treat:
- Hemorrhagic cystitis: Alternatives include hyperhydration (increasing fluid intake) and other protective agents like amifostine. In some cases, reducing the dose of the chemotherapy drug causing the cystitis may also be helpful.
- Bladder cancer: Treatment options may include surgery, radiation therapy, or other chemotherapy agents. Immunotherapy may also be an option for certain patients.
- Cyclophosphamide-induced cystitis: Reducing the dose of cyclophosphamide or switching to a different chemotherapy drug may be considered. Hyperhydration and bladder irrigation are additional potential options.
- Ifosfamide-induced cystitis: Similar to cyclophosphamide-induced cystitis, reducing the dose or switching to another drug may help. Hyperhydration and bladder irrigation are also alternatives.
- Chemotherapy-induced bladder toxicity: In addition to Mesna, other protective agents like amifostine may be used. Reducing the dose of the chemotherapy drug or switching to a different drug may also be considered.
- Radiation cystitis: Treatment options include hyperbaric oxygen therapy, anti-inflammatory medications, and bladder instillations with agents such as hyaluronic acid.
- Nephrotoxicity: Reducing the dose of the offending drug or switching to a less toxic alternative may help. Staying well-hydrated and using medications that protect the kidneys, such as sodium bicarbonate, may also be beneficial.
- Urinary tract infections (UTIs): Antibiotics are the primary treatment for UTIs. Drinking plenty of water and practicing good hygiene can help prevent future infections.
- Bladder inflammation: Anti-inflammatory medications, bladder instillations, and lifestyle changes—such as avoiding irritants like caffeine and alcohol—may help reduce symptoms.
- Renal toxicity: Reducing the dose of the offending drug or switching to a different medication may help. Staying well-hydrated and using medications that protect the kidneys may also be beneficial.
Before making any changes to your treatment plan, it’s essential to discuss these alternatives with your healthcare provider. Our telemedicine providers can help you explore the best options for your specific condition.
Recent Updates on Mesna Research
Recent studies on Mesna have focused on its effectiveness in preventing chemotherapy-induced bladder toxicity and its potential use in other conditions. Ongoing research is exploring whether Mesna can protect other organs, such as the kidneys and liver, from the harmful effects of chemotherapy. Additionally, researchers are investigating whether Mesna could be combined with other protective agents to enhance its effectiveness. While these studies are promising, further research is needed to confirm these findings.
If you have any questions about Mesna or would like to discuss the latest research, our telemedicine providers are available to help you understand how this medication may fit into your treatment plan.
